ANTIFIBRILLATORY AND PROFIBRILLATORY ACTIONS OF SELECTED CLASS-I ANTIARRHYTHMIC AGENTS

被引:0
|
作者
FAGBEMI, SO [1 ]
CHI, L [1 ]
LUCCHESI, BR [1 ]
机构
[1] UNIV MICHIGAN, SCH MED, ANN ARBOR, MI 48109 USA
来源
FASEB JOURNAL | 1992年 / 6卷 / 05期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:A1863 / A1863
页数:1
相关论文
共 50 条
  • [21] EVIDENCE FOR A PROFIBRILLATORY EFFECT OF THE CLASS-I ANTIARRHYTHMIC DRUGS IN MYOCARDIAL-ISCHEMIA GIVEN BY TIME TO ONSET OF FIBRILLATION AND ELECTRICAL FIBRILLATION THRESHOLD
    TIMOUR, Q
    AUPETIT, JF
    LOUFOUAMOUNDANGA, JL
    BARRALCADIERE, L
    FREYSZ, M
    FAUCON, G
    THERAPIE, 1994, 49 (04): : 349 - 353
  • [22] CLASS-I AND CLASS-III ANTIARRHYTHMIC ACTIONS OF PRAZOSIN IN GUINEA-PIG PAPILLARY-MUSCLES
    PEREZ, O
    VALENZUELA, C
    DELPON, E
    TAMARGO, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 111 (03) : 717 - 722
  • [23] ANTIARRHYTHMIC AND ANTIFIBRILLATORY ACTIONS OF THE LEVOROTATORY AND DEXTROROTATORY ISOMERS OF SOTALOL
    LYNCH, JJ
    WILBER, DJ
    MONTGOMERY, DG
    HSIEH, TM
    PATTERSON, E
    LUCCHESI, BR
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1984, 6 (06) : 1132 - 1141
  • [24] THE CLINICAL RELEVANCE OF THE SUBCLASSIFICATION OF CLASS-I ANTIARRHYTHMIC DRUGS
    CAMPBELL, T
    CURRENT TOPICS IN ANTIARRHYTHMIC AGENTS: MODE OF ACTION AND CLINICAL USAGE, 1989, 56 : 201 - 212
  • [25] EFFECTS OF CLASS-I ANTIARRHYTHMIC DRUGS IN INFARCTED TISSUE
    MAN, RYK
    BRIL, A
    CLINICAL AND INVESTIGATIVE MEDICINE, 1991, 14 (05): : 466 - 475
  • [26] DIFFERENTIAL INHIBITION OF K+ CURRENTS IN RAT VENTRICULAR MYOCYTES BY CLASS-I ANTIARRHYTHMIC AGENTS
    SLAWSKY, MT
    CASTLE, NA
    BIOPHYSICAL JOURNAL, 1993, 64 (02) : A394 - A394
  • [27] FREQUENCY-DEPENDENT EFFECTS OF CLASS-I ANTIARRHYTHMIC AGENTS STUDIED IN PATIENTS WITH IMPLANTED PACEMAKERS
    TAKANAKA, C
    LEE, JK
    NONOKAWA, M
    SUGIYAMA, T
    YAME, S
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1994, 17 (11): : 2100 - 2105
  • [28] IDIOPATHIC VENTRICULAR-FIBRILLATION - INDUCIBILITY AND BENEFICIAL-EFFECTS OF CLASS-I ANTIARRHYTHMIC AGENTS
    BELHASSEN, B
    SHAPIRA, I
    SHOSHANI, D
    PAREDES, A
    MILLER, H
    LANIADO, S
    CIRCULATION, 1987, 75 (04) : 809 - 816
  • [29] ELECTROPHARMACOLOGY OF NONSUSTAINED VENTRICULAR-TACHYCARDIA - EFFECTS OF CLASS-I ANTIARRHYTHMIC AGENTS, VERAPAMIL AND PROPRANOLOL
    BUXTON, AE
    WAXMAN, HL
    MARCHLINSKI, FE
    JOSEPHSON, ME
    AMERICAN JOURNAL OF CARDIOLOGY, 1984, 53 (06): : 738 - 744
  • [30] ANTIFIBRILLATORY ACTIVITY OF THE CLASS-III ANTIARRHYTHMIC AGENTS, RISOTILIDE AND SEMATILIDE, IN ANESTHETIZED RATS
    KAUFFMAN, JA
    SALATA, JJ
    FALOTICO, R
    TOBIA, AJ
    FASEB JOURNAL, 1991, 5 (05): : A1215 - A1215